Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2017

01-09-2017 | Original Article

Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program

Authors: Ding Ye, Qiuchi Huang, Qilong Li, Xiyi Jiang, Mayila Mamat, Mengling Tang, Jianbing Wang, Kun Chen

Published in: Digestive Diseases and Sciences | Issue 9/2017

Login to get access

Abstract

Background

The fecal immunochemical test (FIT) has been widely used in preliminary screening for colorectal cancer (CRC). The high-risk factor questionnaire (HRFQ) and quantitative risk-assessment method (QRAM) are recommended for estimating the risk of CRC qualitatively and quantitatively in China.

Aim

We aimed to prospectively compare the diagnostic values of CRC preliminary screening methods to identify which method is preferable as a screening strategy.

Methods

Individuals aged 40–74 years old were enrolled in a mass CRC screening program from January 1, 2007 to December 31, 2014, in Jiashan County, Zhejiang Province, China. FIT of two stool specimens at 1-week intervals was performed by laboratory personnel and face-to-face interviews were conducted by trained investigators. Screening data in the program were linked to a CRC surveillance and registry system, and CRC cases reported in the system were regarded as true patients.

Results

A total of 96,043 subjects were included. The sensitivity and specificity of FIT for detecting CRC cases were 75.49% (95% CI 69.84–80.39) and 90.36% (95% CI 90.17–90.54), respectively. QRAM was more sensitive (p < 0.001) and less specific (p < 0.001) than HRFQ. The sensitivity and specificity of FIT along with HRFQ were 86.56% (95% CI 81.81–90.22) and 81.37% (95% CI 81.12–81.62), and those of FIT along with QRAM were 88.93% (95% CI 84.47–92.23) and 73.95% (95% CI 73.67–74.23).

Conclusions

Our findings suggest that CRC preliminary screening with FIT and QRAM in parallel has high sensitivity and satisfactory specificity, and is a useful strategy in mass screening programs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. New Engl J Med. 1993;328:1365–1371.CrossRefPubMed Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. New Engl J Med. 1993;328:1365–1371.CrossRefPubMed
2.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.CrossRefPubMed
3.
go back to reference Rabeneck L, Paszat LF, Saskin R, Stukel TA. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol. 2010;105:1627–1632.CrossRefPubMed Rabeneck L, Paszat LF, Saskin R, Stukel TA. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol. 2010;105:1627–1632.CrossRefPubMed
4.
go back to reference Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.CrossRefPubMed Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.CrossRefPubMed
5.
go back to reference Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015;25:208–213.CrossRefPubMed Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015;25:208–213.CrossRefPubMed
6.
go back to reference Bibbins-Domingo K, Grossman DC, Curry SJ, et al. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564–2575.CrossRefPubMed Bibbins-Domingo K, Grossman DC, Curry SJ, et al. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564–2575.CrossRefPubMed
7.
go back to reference Segnan N, Patnick J, von Karsa L, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: European Commission, Publications Office of the European Union; 2010. Segnan N, Patnick J, von Karsa L, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: European Commission, Publications Office of the European Union; 2010.
8.
go back to reference Provenzale D, Jasperson K, Ahnen DJ, et al. Colorectal cancer screening, version 1.2015. J Natl Compr Canc Netw. 2015;13:959–968.CrossRefPubMed Provenzale D, Jasperson K, Ahnen DJ, et al. Colorectal cancer screening, version 1.2015. J Natl Compr Canc Netw. 2015;13:959–968.CrossRefPubMed
9.
go back to reference Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132.CrossRefPubMed Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132.CrossRefPubMed
10.
go back to reference Arbyn M, Van Oyen H, Lynge E, Micksche M, Faivre J, Jordan J. European Commission’s proposal for a council recommendation on cancer screening. BMJ. 2003;327:289–290.CrossRefPubMedPubMedCentral Arbyn M, Van Oyen H, Lynge E, Micksche M, Faivre J, Jordan J. European Commission’s proposal for a council recommendation on cancer screening. BMJ. 2003;327:289–290.CrossRefPubMedPubMedCentral
11.
go back to reference Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–560.CrossRefPubMed Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–560.CrossRefPubMed
12.
go back to reference Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test. Hemoccult BMJ. 1998;317:559–565.CrossRefPubMed Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test. Hemoccult BMJ. 1998;317:559–565.CrossRefPubMed
13.
go back to reference Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.CrossRefPubMed
14.
go back to reference Jessup JM, Menck HR, Fremgen A, Winchester DP. Diagnosing colorectal carcinoma: clinical and molecular approaches. CA Cancer J Clin. 1997;47:70–92.CrossRefPubMed Jessup JM, Menck HR, Fremgen A, Winchester DP. Diagnosing colorectal carcinoma: clinical and molecular approaches. CA Cancer J Clin. 1997;47:70–92.CrossRefPubMed
15.
go back to reference Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.CrossRefPubMed Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.CrossRefPubMed
16.
go back to reference Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol. 2009;15:6111–6116.CrossRefPubMedPubMedCentral Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol. 2009;15:6111–6116.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Zheng S, Chen K, Liu XY, et al. Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum. 2003;46:51–58.CrossRefPubMed Zheng S, Chen K, Liu XY, et al. Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum. 2003;46:51–58.CrossRefPubMed
19.
go back to reference Sarkar R, Dey S, Pal M, et al. Risk prediction for oral potentially malignant disorders using fuzzy analysis of cytomorphological and autofluorescence alterations in habitual smokers. Future Oncol. 2017;13:499–511.CrossRefPubMed Sarkar R, Dey S, Pal M, et al. Risk prediction for oral potentially malignant disorders using fuzzy analysis of cytomorphological and autofluorescence alterations in habitual smokers. Future Oncol. 2017;13:499–511.CrossRefPubMed
20.
go back to reference Hu Y, Wang Z, Wen J, Li Y. Stochastic fuzzy environmental risk characterization of uncertainty and variability in risk assessments: a case study of polycyclic aromatic hydrocarbons in soil at a petroleum-contaminated site in China. J Hazard Mater. 2016;316:143–150.CrossRefPubMed Hu Y, Wang Z, Wen J, Li Y. Stochastic fuzzy environmental risk characterization of uncertainty and variability in risk assessments: a case study of polycyclic aromatic hydrocarbons in soil at a petroleum-contaminated site in China. J Hazard Mater. 2016;316:143–150.CrossRefPubMed
21.
go back to reference Beheshti I, Olya HG, Demirel H. Risk assessment of Alzheimer’s disease using the information diffusion model from structural magnetic resonance imaging. J Alzheimers Dis. 2016;52:1335–1342.CrossRefPubMed Beheshti I, Olya HG, Demirel H. Risk assessment of Alzheimer’s disease using the information diffusion model from structural magnetic resonance imaging. J Alzheimers Dis. 2016;52:1335–1342.CrossRefPubMed
22.
go back to reference Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.CrossRefPubMed Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.CrossRefPubMed
23.
go back to reference Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed
24.
go back to reference Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015;163:339–346.CrossRefPubMedPubMedCentral Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015;163:339–346.CrossRefPubMedPubMedCentral
25.
go back to reference Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49:3049–3054.CrossRefPubMed Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49:3049–3054.CrossRefPubMed
26.
go back to reference Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer I. 2007;99:1462–1470.CrossRef Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer I. 2007;99:1462–1470.CrossRef
27.
go back to reference Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer. 2005;115:493–496.CrossRefPubMed Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer. 2005;115:493–496.CrossRefPubMed
28.
go back to reference Levi Z, Birkenfeld S, Vilkin A, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. a prospective, controlled, feasibility study. Int J Cancer. 2011;128:2415–2424.CrossRefPubMed Levi Z, Birkenfeld S, Vilkin A, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. a prospective, controlled, feasibility study. Int J Cancer. 2011;128:2415–2424.CrossRefPubMed
29.
30.
go back to reference Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.CrossRefPubMed Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.CrossRefPubMed
31.
go back to reference Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010;138:877–885.CrossRefPubMed Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010;138:877–885.CrossRefPubMed
32.
go back to reference Taylor DP, Stoddard GJ, Burt RW, et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med. 2011;13:385–391.CrossRefPubMed Taylor DP, Stoddard GJ, Burt RW, et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med. 2011;13:385–391.CrossRefPubMed
33.
go back to reference Holme O, Bretthauer M, Eide TJ, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut. 2015;64:929–936.CrossRefPubMed Holme O, Bretthauer M, Eide TJ, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut. 2015;64:929–936.CrossRefPubMed
34.
go back to reference Schoen RE, Weissfeld JL, Kuller LH. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol. 1994;89:835–842.PubMed Schoen RE, Weissfeld JL, Kuller LH. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol. 1994;89:835–842.PubMed
36.
go back to reference Betes M, Munoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98:2648–2654.PubMed Betes M, Munoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98:2648–2654.PubMed
38.
go back to reference Dunlop MG, Tenesa A, Farrington SM, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut. 2013;62:871–881.CrossRefPubMed Dunlop MG, Tenesa A, Farrington SM, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut. 2013;62:871–881.CrossRefPubMed
39.
go back to reference Cheng JM, Chen Y, Wang XL, et al. Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers. Eur J Cancer Prev. 2015;24:6–15.CrossRefPubMed Cheng JM, Chen Y, Wang XL, et al. Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers. Eur J Cancer Prev. 2015;24:6–15.CrossRefPubMed
40.
go back to reference Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose–response meta-analysis of published studies. Ann Oncol. 2011;22:1958–1972.CrossRefPubMed Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose–response meta-analysis of published studies. Ann Oncol. 2011;22:1958–1972.CrossRefPubMed
41.
go back to reference Robsahm TE, Aagnes B, Hjartaker A, Langseth H, Bray FI, Larsen IK. Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J Cancer Prev. 2013;22:492–505.CrossRefPubMed Robsahm TE, Aagnes B, Hjartaker A, Langseth H, Bray FI, Larsen IK. Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J Cancer Prev. 2013;22:492–505.CrossRefPubMed
42.
go back to reference Murphy N, Norat T, Ferrari P, et al. Dietary fibre intake and risks of cancers of the colon and rectum in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS ONE. 2012;7:e39361.CrossRefPubMedPubMedCentral Murphy N, Norat T, Ferrari P, et al. Dietary fibre intake and risks of cancers of the colon and rectum in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS ONE. 2012;7:e39361.CrossRefPubMedPubMedCentral
43.
go back to reference Pham NM, Mizoue T, Tanaka K, et al. Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2014;44:641–650.CrossRefPubMed Pham NM, Mizoue T, Tanaka K, et al. Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2014;44:641–650.CrossRefPubMed
44.
go back to reference van Dam L, Kuipers EJ, Steyerberg EW, van Leerdam ME, de Beaufort ID. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol. 2013;14:e38–e46.CrossRefPubMed van Dam L, Kuipers EJ, Steyerberg EW, van Leerdam ME, de Beaufort ID. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol. 2013;14:e38–e46.CrossRefPubMed
45.
go back to reference Seeff LC, DeGroff A, Joseph DA, et al. Moving forward: using the experience of the CDCs’ colorectal cancer screening demonstration program to guide future colorectal cancer programming efforts. Cancer. 2013;119:2940–2946.CrossRefPubMed Seeff LC, DeGroff A, Joseph DA, et al. Moving forward: using the experience of the CDCs’ colorectal cancer screening demonstration program to guide future colorectal cancer programming efforts. Cancer. 2013;119:2940–2946.CrossRefPubMed
Metadata
Title
Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program
Authors
Ding Ye
Qiuchi Huang
Qilong Li
Xiyi Jiang
Mayila Mamat
Mengling Tang
Jianbing Wang
Kun Chen
Publication date
01-09-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4648-1

Other articles of this Issue 9/2017

Digestive Diseases and Sciences 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.